Therefore, due to the small number of reports and the statistical limitations, we currently lack sufficient evidence to explore potential associations between GLP-1 RAs and concomitant medications in the development of cholecystitis and cholelithiasis. This evidence concerns the gene GLP1R and Cholecystitis.